scholarly article | Q13442814 |
P2093 | author name string | Norman R Harris | |
Wendy Leskova | |||
Minsup Lee | |||
Randa S Eshaq | |||
P2860 | cites work | Retinal degeneration mutants in the mouse | Q28202375 |
Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier | Q28235057 | ||
Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine | Q28235275 | ||
Mechanisms of neurotransmitter release by amphetamines: a review | Q28256434 | ||
The blood-brain barrier: an overview: structure, regulation, and clinical implications | Q29616839 | ||
PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics | Q31825950 | ||
Matrix metalloproteinases in human diabetic and nondiabetic vitreous | Q32058683 | ||
Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration | Q33188043 | ||
Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras | Q34022639 | ||
Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress | Q34504916 | ||
Ocular manifestations of crystal methamphetamine use. | Q34977154 | ||
Protease Activity and the Role of the Endothelial Glycocalyx in Inflammation | Q35503145 | ||
Mechanisms of methamphetamine-induced dopaminergic neurotoxicity | Q35594901 | ||
The TNF-α/NF-κB signaling pathway has a key role in methamphetamine-induced blood-brain barrier dysfunction | Q35925469 | ||
Gap junction contributions to the goldfish electroretinogram at the photopic illumination level | Q36089815 | ||
Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates | Q36305029 | ||
MT1-MMP: a key regulator of cell migration in tissue | Q36627872 | ||
Relationship between methamphetamine exposure and matrix metalloproteinase 9 expression | Q37052569 | ||
Cerebrovascular complications of methamphetamine abuse | Q37365316 | ||
MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury | Q37716860 | ||
Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential | Q37750085 | ||
PECAM-1: regulator of endothelial junctional integrity | Q38179296 | ||
Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release. | Q38302183 | ||
Breakdown of Blood-Brain and Blood-Spinal Cord Barriers During Acute Methamphetamine Intoxication: Role of Brain Temperature | Q39361706 | ||
MMP-14 mediated MMP-9 expression is involved in TGF-beta1-induced keratinocyte migration | Q40007919 | ||
Significance of outer blood-retina barrier breakdown in diabetes and ischemia | Q41924777 | ||
Toxic effect of methamphetamine on the retina of CD1 mice | Q42184970 | ||
Cardiac remodeling after long term norepinephrine treatment in rats. | Q43782715 | ||
Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells | Q43825285 | ||
Modeling human methamphetamine use patterns in mice: chronic and binge methamphetamine exposure, reward function and neurochemistry. | Q43847144 | ||
Methamphetamine-induced TNF-alpha gene expression and activation of AP-1 in discrete regions of mouse brain: potential role of reactive oxygen intermediates and lipid peroxidation | Q44135794 | ||
Methamphetamine exacerbates the toxic effect of kainic acid in the adult rat retina. | Q45068514 | ||
Ischemic stroke associated with methamphetamine inhalation | Q46549559 | ||
Matrix metalloproteinases MMP2 and MMP9 are upregulated by noradrenaline in the mouse neuroendocrine hypothalamus | Q46684384 | ||
Central retinal artery occlusion associated with intranasal methamphetamine use. | Q46975802 | ||
Clinical Characteristics of Fatal Methamphetamine-related Stroke: A National Study | Q47639400 | ||
Production and Activation of Matrix Metalloproteinase-2 in Proliferative Diabetic Retinopathy | Q47952325 | ||
Dopamine and serotonin in cat retina: electroretinography and histology | Q48160487 | ||
Methamphetamine Causes Photoreceptor Cell Damage Through Promoting Polarization of Macrophages and Inducing Inflammatory Response | Q48185553 | ||
Methamphetamine use and future risk for Parkinson's disease: Evidence and clinical implications. | Q52582675 | ||
Enhanced phosphorylation of MAPKs by NE promotes TNF-α production by macrophage through α adrenergic receptor. | Q54589154 | ||
Long-Term Systemic Treatment With Methamphetamine Causes Retinal Damage in CD1 Mice | Q58103602 | ||
Loss of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) in the Diabetic Retina: Role of Matrix Metalloproteinases | Q64270971 | ||
Bilateral methamphetamine-induced ischemic retinopathy. | Q64890577 | ||
Amaurosis fugax and retinal vasculitis associated with methamphetamine inhalation. | Q64979623 | ||
Sudden Retinal Manifestations of Intranasal Cocaine and Methamphetamine Abuse | Q68231429 | ||
Recurrent corneal ulcerations associated with smokeable methamphetamine abuse | Q71025501 | ||
Keratitis in methamphetamine abusers | Q71666371 | ||
Acute unilateral visual loss due to a single intranasal methamphetamine abuse | Q77832306 | ||
Effects of crocetin on the matrix metalloproteinases in cardiac hypertrophy induced by norepinephrine in rats | Q79974542 | ||
Crystalline retinopathy from nasal ingestion of methamphetamine | Q80237860 | ||
Catecholamines can induce pulmonary remodeling in rats | Q85502682 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P304 | page(s) | 107964 | |
P577 | publication date | 2020-02-07 | |
P1433 | published in | Experimental Eye Research | Q15754753 |
P1476 | title | Acute changes in the retina and central retinal artery with methamphetamine | |
P478 | volume | 193 |